unknown
Stage
2018
Founded
3
Investors
About
Carisma Therapeutics is a biotechnology company developing CAR-macrophage therapies to treat cancer by fully activating the immune system to recognize and eliminate tumor cells.
Explore Carisma Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.